New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma

Published:2020-07 Issue: Volume:51 Page:100702
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Dal Bo Michele,De Mattia Elena,Baboci Lorena,Mezzalira Silvia,Cecchin Erika,Assaraf Yehuda G.,Toffoli Giuseppe

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference265 articles.

1. Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma;Abou-Alfa;J. Hepatol.,2016

2. Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC);Abou-Alfa;Cancer Chemother. Pharmacol.,2017

3. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma;Abou-Alfa;N. Engl. J. Med.,2018

4. Systematic review of case reports on the abscopal effect;Abuodeh;Curr. Probl. Cancer,2016

5. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial;Alunni-Fabbroni;J. Transl. Med.,2019

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment;Frontiers in Immunology;2024-09-03

2. Efficacy of doxorubicin and lipiodol therapy by trans-arterial chemoembolization in hepatocellular carcinoma Egyptian patients and relation to genetic polymorphisms;Expert Review of Anticancer Therapy;2024-08-21

3. Phase separation of RNF214 promotes the progression of hepatocellular carcinoma;Cell Death & Disease;2024-07-05

4. The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma;Cancer Immunology, Immunotherapy;2024-07-02

5. Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies;International Journal of Molecular Sciences;2024-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3